common.study.topics.clinical

NIR Fluorescence Imaging of Lymphatic Transport Using ICG

common.study.values.description

“NIR Fluorescence Imaging of Lymphatic Transport Using ICG”

In this phase 1 study, the lymphatic transport will be examined using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) of the upper extremities in healthy individuals using a MultiSpectral Imaging System (MSImager).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Indocyanine Green

A trained physician will inject 0.1 ml of Indocyanine Green into the web spaces of the hands in both upper extremities. Subjects may have up to five study visits to confirm feasibility, safety, and reproducibility.

Device - MultiSpectral Imaging System

Once the Indocyanine Green is injected, the contrast is expected to fluoresce underneath the MultiSpectral Imaging System. Multispectral video and still images will be recorded at the study visits.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Near InfraRed Fluorescence Imaging of Lymphatic Transport Using Indocyanine Green

common.study.values.clinical-trial-id

NCT02680067

participant.views.study.view.id

negMjb